No company can match StemCyte's LifeSaver Guarantee!
With StemCyte's Hybrid model you will naturally
receive support and options at NO additional cost
If for any reason your newborn's cord blood unit fails to engraft, StemCyte's LifeSaver Guarantee will:
-
Find a replacement at no cost to parents from StemCyte's public inventory.
-
Refund All Fees.
-
Provide parents with an additional $50k.
Cord Blood & Tissue Banking
Cord Blood & Tissue Banking
Cord Blood & Tissue Banking
MaxCell®
Annual Cord Blood Plans
FDA Approved Treatments
Cord Blood Stem Cells
FDA Approved Treatments
Cord Blood Stem Cells
Cord Blood Cord blood contains a rich source of various cells including hematopoietic stem cells which form blood cells. Today, there are 80 diseases that can be treated with cord blood stem cells. Also, there are more than 100 active cord blood stem cell clinical trials worldwide investigating the treatment of various diseases like autism.
An Overview
StemCyte's Top Advantages
There are many important things to consider before choosing a company to preserve your newborn's cord blood and cord tissue. As pioneers in regenerative medicine, StemCyte knows what truly matters at every step of banking. We hope this list of our top advantages will give you the confidence in our science, products, and the people who will care for your family's future health and well-being.
脐带血干细胞移植的
历史发展
您知道初产妇的平均年龄是30岁吗？恰巧脐带血发展历史也是30多年。你相信吗？在短短30年的发展历史中，脐带血已经有许多非常成功的医疗应用，也拯救了许多人的性命。对于准父母来说，好消息是脐带血干细胞的治疗方法已被证明对80多种疾病有疗效，更好的消息是，持续不断地有更多的新疗法和应用可治疗更多疾病。这就是为什么StemCyte鼓励您储存脐带血和脐带组织，可以让您在未来漫长的岁月中保护到您的孩子和家人。
1st
Transplant
40k
1983
脐带血移植的概念诞生。
1985
首次脐带血干细胞移植成为可能。
1988
首次成功的脐带血移植-----
一位5岁儿童使用妹妹的脐带血移植。
1992
公共脐带血库陆续成立
1993
杜克大学医学院的Joanne Kurtzburg医学博士在美国进行第一例脐带血移植。
1993
世界各地的私人脐带血库开始经营。
2011
FDA 首次批准了脐带血干细胞针对脑瘫的临床实验。
2016
自1988年以来，全球已经有40,000的脐带血移植案例。
2020
FDA 已经开放对脐带血和脐带组织的新医疗用途，批准了许多临床实验，包含自闭症、糖尿病、中风、脊髓损伤，及心脏病等，干细胞的应用已带来崭新的希望与未来。